Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Terumo (JP:4543)
TSE/TYO:4543
Holding JP:4543?
Track your performance easily
4543 Stock Chart & Stats
Day’s Range¥0 - ¥0
52-Week Range¥2,134.00 - ¥3,182.00
Previous Close¥3,038
Volume2.36M
Average Volume (3M)4.92M
Market Cap
¥4.52T
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)37.8
Beta0.88
Next Earnings
Feb 06, 2025EPS Estimate
¥25.34Next Dividend Ex-Date
Mar 28, 2025Dividend Yield0.86%
Share Statistics
EPS (TTM)80.43
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume4,920,409
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥3,392.21Price Target Upside10.39% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Terumo News
PremiumCompany Announcements
Terumo Corporation Reports Strong First Half 2024 Results
PremiumCompany Announcements
Terumo Corp Raises Financial Forecast Amid Strong Revenue
PremiumPre-Earnings
Is TRUMF a Buy, Before Earnings?PremiumCompany Announcements
Terumo Completes Share Buyback Program
PremiumCompany Announcements
Terumo Sets Dates for 30 Billion Yen Share Buyback
PremiumCompany Announcements
Terumo Sets Offer Price for International Share Sale
PremiumCompany Announcements
Terumo Announces Share Buyback and Cancellation PlanPremiumCompany Announcements
Terumo Announces Secondary Offering and Share Buyback PlanBulls Say, Bears Say
Bulls Say
Market ExpansionThe joint venture with Weigao Blood Purification allows Terumo to tap into China's large market, potentially increasing its market presence.
Material AdvancementsIt is following the market movement from predominantly glass-focused syringes to polymeric materials, bringing along multiple benefits including higher break resistance and less risk of reaction with drugs.
Product InnovationTerumo has been recognized for its innovative needle technology, making it a top choice for pharmaceutical packaging of popular GLP-1 weight loss drugs.
Bears Say
Growth OpportunitiesThe delay in the IPO of Weigao Blood Purification could be detrimental to Terumo, as the listing could boost growth.
Market CompetitionThere is a risk of price cuts for hemodialysis systems in China due to the country's Volume Based Procurement scheme.
Strategic SetbacksThe delay in the IPO of Weigao Blood Purification on the HKEX could be detrimental to Terumo, as the listing could boost growth.
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
8.42% Mutual Funds
<0.01% Other Institutional Investors
83.93% Public Companies and
Individual Investors
4543 FAQ
What was Terumo’s price range in the past 12 months?
Terumo lowest stock price was ¥2134.00 and its highest was ¥3182.00 in the past 12 months.
What is Terumo’s market cap?
Currently, no data Available
When is Terumo’s upcoming earnings report date?
Terumo’s upcoming earnings report date is Feb 06, 2025 which is in 75 days.
How were Terumo’s earnings last quarter?
Terumo released its earnings results on Nov 07, 2024. The company reported ¥19.75 earnings per share for the quarter, missing the consensus estimate of ¥22.122 by -¥2.372.
Is Terumo overvalued?
According to Wall Street analysts Terumo’s price is currently Undervalued.
Does Terumo pay dividends?
Terumo pays a Annually dividend of ¥13 which represents an annual dividend yield of 0.86%. See more information on Terumo dividends here
What is Terumo’s EPS estimate?
Terumo’s EPS estimate is ¥25.34.
How many shares outstanding does Terumo have?
Terumo has 1,490,697,300 shares outstanding.
What happened to Terumo’s price movement after its last earnings report?
Terumo reported an EPS of ¥19.75 in its last earnings report, missing expectations of ¥22.122. Following the earnings report the stock price went up 0.303%.
Which hedge fund is a major shareholder of Terumo?
Currently, no hedge funds are holding shares in JP:4543
---
Terumo Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
¥3,392.21 (10.39% Upside)
¥3,392.21 (10.39% Upside)
Blogger Sentiment
Bullish
JP:4543 Sentiment 100%
Sector Average 71%
Sector Average 71%
Technicals
SMA
Positive
20 days / 200 days
Momentum
33.13%
12-Months-Change
Fundamentals
Return on Equity
9.00%
Trailing 12-Months
Asset Growth
4.55%
Trailing 12-Months
Company Description
Terumo
Terumo Corp. engages in the manufacturing and sale of medical products and equipment. It operates through the following segments: Cardiac and Vascular Company, General Hospital Company, and Blood Management Company. The Cardiac and Vascular Company segment offers services and treatments including cardiac and vascular surgery and interventional therapies performed inside blood vessels. The General Hospital Company segment provides infusion and closed anticancer drug infusion systems, measuring devices system with communication functions, diabetes management, adhesion barrier, and peritoneal dialysis. The Blood Management Company segment offers a combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. The company was founded by Shibasaburo Kitasato on September 17, 1921 and is headquartered in Tokyo, Japan
---
4543 Company Deck
---
4543 Earnings Call
Q2 2024
0:00 / 0:00
---
4543 Stock 12 Month Forecast
Average Price Target
¥3,392.21
▲(10.39% Upside)
Technical Analysis
Best Analysts Covering 4543
1 Year
1 Year Success Rate
4/6 ratings generated profit
1 Year Average Return
+4.30%
reiterated a buy rating 4 months ago
Copying Naoko Saito's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +4.30% per trade.
---